Apoptosis initiation through the cell-extrinsic pathway

Methods in Enzymology

Volumn 544, Issue , 2014, Pages 99-128

  Nair, Pradeep ^a   Lu, Min ^a   Petersen, Sean ^a   Ashkenazi, Avi ^a  

^a GENENTECH INC   (United States)

Author keywords

Apo2L TRAIL; Caspase 8; cFLIP; Cullin 3; Death receptor; FAAD; FasL CD95L; Necroptosis; TNF; Ubiquitination

Indexed keywords

CASPASE 10; CASPASE 3; CASPASE 8; CASPASE INHIBITOR; CLATHRIN HEAVY CHAIN; DEATH RECEPTOR; DEATH RECEPTOR 4; DEATH RECEPTOR 5; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLICE INHIBITORY PROTEIN; LIGAND; MEMBRANE RECEPTOR; MUTANT PROTEIN; PROTEIN BCL 2; PROTEIN TYROSINE KINASE; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UBIQUITIN PROTEIN LIGASE E3; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; CELL MEMBRANE; CELL SURFACE; CYTOTOXICITY; DIMERIZATION; EMBRYO DEVELOPMENT; EMBRYOPATHY; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INTERNALIZATION; INTRACELLULAR SIGNALING; LIGAND BINDING; MEMBRANE STRUCTURE; NECROPTOSIS; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; STOICHIOMETRY; TARGET CELL; UBIQUITINATION; ANIMAL; GENETICS; METABOLISM; MUTATION; NECROSIS; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CASPASE 8; ENZYME ACTIVATION; HUMANS; MUTATION; NECROSIS; RECEPTORS, DEATH DOMAIN; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 84903483805     PISSN: 00766879     EISSN: 15577988     Source Type: Book Series    
DOI: 10.1016/B978-0-12-417158-9.00005-4     Document Type: Chapter

References (130)

1. C. Adams, K. Totpal, D. Lawrence, S. Marsters, R. Pitti, and S. Yee et al. Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5 Cell Death and Differentiation 15 2008 751 761
2. A. Ashkenazi Directing cancer cells to self-destruct with pro-apoptotic receptor agonists Nature Reviews. Drug Discovery 7 2008 1001 1012
3. A. Ashkenazi, and V.M. Dixit Death receptors: Signaling and modulation Science 281 1998 1305 1308
4. A. Ashkenazi, and R.S. Herbst To kill a tumor cell: The potential of proapoptotic receptor agonists The Journal of Clinical Investigation 118 2008 1979 1990
5. C.D. Austin, D.A. Lawrence, A.A. Peden, E.E. Varfolomeev, K. Totpal, and A.M. De Mazière et al. Death-receptor activation halts clathrin-dependent endocytosis Proceedings of the National Academy of Sciences of the United States of America 103 2006 10283 10288
6. J. Beaudouin, C. Liesche, S. Aschenbrenner, M. Hörner, and R. Eils Caspase-8 cleaves its substrates from the plasma membrane upon CD95-induced apoptosis Cell Death and Differentiation 20 2013 599 610
7. A.B. Berger, K.B. Sexton, and M. Bogyo Commonly used caspase inhibitors designed based on substrate specificity profiles lack selectivity Cell Research 16 2006 961 963
8. M.J.M. Bertrand, and P. Vandenabeele The ripoptosome: Death decision in the cytosol Molecular Cell 43 2011 323 325
9. S. Biton, and A. Ashkenazi NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-α feedforward signaling Cell 145 2011 92 103
10. K.M. Boatright, M. Renatus, F.L. Scott, S. Sperandio, H. Shin, and I.M. Pedersen et al. A unified model for apical caspase activation Molecular Cell 11 2003 529 541
11. M.P. Boldin, T.M. Goncharov, Y.V. Goltsev, and D. Wallach Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death Cell 85 1996 803 815
12. J.S. Bonifacino, and L.M. Traub Signals for sorting of transmembrane proteins to endosomes and lysosomes Annual Review of Biochemistry 72 2003 395 447
13. S. Bryde, I. Grunwald, A. Hammer, A. Krippner-Heidenreich, T. Schiestel, and H. Brunner et al. Tumor necrosis factor (TNF)-functionalized nanostructured particles for the stimulation of membrane TNF-specific cell responses Bioconjugate Chemistry 16 2005 1459 1467
14. M.A. Cassatella, V. Huber, F. Calzetti, D. Margotto, N. Tamassia, and G. Peri et al. Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators Journal of Leukocyte Biology 79 2006 123 132
15. B. Chaigne-Delalande, J.-F. Moreau, and P. Legembre Rewinding the DISC Archivum Immunologiae et Therapiae Experimentalis 56 2008 9 14
16. K. Chakrabandhu, Z. Hérincs, S. Huault, B. Dost, L. Peng, and F. Conchonaud et al. Palmitoylation is required for efficient Fas cell death signaling The EMBO Journal 26 2007 209 220
17. F.K.-M. Chan A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling Science 288 2000 2351 2354
18. L.F. Chang, H. Kamata, G. Solinas, J.L. Luo, S. Maeda, and K. Venuprasad et al. The E3 ubiquitin ligase itch couples JNK activation to TNF alpha-induced cell death by inducing c-FLIPL turnover Cell 124 2006 601 613
19. D.W. Chang, Z. Xing, Y. Pan, A. Algeciras-Schimnich, B.C. Barnhart, and S. Yaish-Ohad et al. c-FLIPL is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis The EMBO Journal 21 2002 3704 3714
20. D. Chauvier, S. Ankri, C. Charriaut-Marlangue, R. Casimir, and E. Jacotot Broad-spectrum caspase inhibitors: From myth to reality? Cell Death and Differentiation 14 2007 387 391
21. K.F. Chen, C.Y. Liu, Y.C. Lin, H.C. Yu, T.H. Liu, and D.R. Hou et al. CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells Oncogene 29 2010 6257 6266
22. W. Chen, Z. Zhou, L. Li, C.Q. Zhong, X. Zheng, and X. Wu et al. Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling The Journal of Biological Chemistry 288 2013 16247 16261
23. X. Chen, W. Li, J. Ren, D. Huang, W. He, and Y. Song et al. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death Cell Research 24 2014 105 121
24. Y.S. Cho, S. Challa, D. Moquin, R. Genga, T.D. Ray, and M. Guildford et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation Cell 137 2009 1112 1123
25. V. Cortez-Retamozo, N. Backmann, P.D. Senter, U. Wernery, P. De Baetselier, and S. Muyldermans et al. Efficient cancer therapy with a nanobody-based conjugate Cancer Research 64 2004 2853 2857
26. S. Cory, and J.M. Adams The Bcl2 family: Regulators of the cellular life-or-death switch Nature Reviews. Cancer 2 2002 647 656
27. A. Cox, A.M. Dunning, M. Garcia-Closas, S. Balasubramanian, M.W.R. Reed, and K.A. Pooley et al. A common coding variant in CASP8 is associated with breast cancer risk Nature Genetics 39 2007 352 358
28. K. Cseh, and B. Beutlers Alternative cleavage of the cachectin/tumor necrosis factor propeptide results in a larger, inactive form of secreted protein The Journal of Biological Chemistry 264 1989 16256 16260
29. S. Cursi, A. Rufini, V. Stagni, I. Condo, V. Matafora, and A. Bachi et al. Src kinase phosphorylates caspase-8 on Tyr380: A novel mechanism of apoptosis suppression The EMBO Journal 25 2006 1895 1905
30. N.N. Danial, and S.J. Korsmeyer Cell death: Critical control points Cell 116 2004 205 219
31. A. Degterev, J. Hitomi, M. Germscheid, I.L. Ch-en, O. Korkina, and X. Teng et al. Identification of RIP1 kinase as a specific cellular target of necrostatins Nature Chemical Biology 4 2008 313 321
32. L.S. Dickens, R.S. Boyd, R. Jukes-Jones, M.A. Hughes, G.L. Robinson, and L. Fairall et al. A death effector domain chain DISC model reveals a crucial role for caspase-8 chain assembly in mediating apoptotic cell death Molecular Cell 47 2012 291 305
33. C.P. Dillon, A. Oberst, R. Weinlich, L.J. Janke, T.B. Kang, and T. Ben-Moshe et al. Survival function of the FADD-caspase-8-cFLIP(L) complex Cell Reports 1 2012 401 407
34. M. Donepudi, A. Mac Sweeney, C. Briand, and M.G. Grutter Insights into the regulatory mechanism for caspase-8 activation Molecular Cell 11 2003 543 549
35. M.L. Dustin, S.K. Bromley, M.M. Davis, and C. Zhu Identification of self through two-dimensional chemistry and synapses Annual Review of Cell and Developmental Biology 17 2001 133 157
36. S. Ehrlich, C. Infante-Duarte, B. Seeger, and F. Zipp Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytes Cytokine 24 2003 244 253
37. P.M. Eimon, E. Kratz, E. Varfolomeev, S.G. Hymowitz, H. Stern, and J. Zha et al. Delineation of the cell-extrinsic apoptosis pathway in the zebrafish Cell Death and Differentiation 13 2006 1619 1630
38. C. Feig, V. Tchikov, S. Schütze, and M.E. Peter Palmitoylation of CD95 facilitates formation of SDS-stable receptor aggregates that initiate apoptosis signaling The EMBO Journal 26 2007 221 231
39. N. Fricker, J. Beaudouin, P. Richter, R. Eils, P.H. Krammer, and I.N. Lavrik Model-based dissection of CD95 signaling dynamics reveals both a pro- and antiapoptotic role of c-FLIPL The Journal of Cell Biology 190 2010 377 389
40. M. Gao, T. Labuda, Y. Xia, E. Gallagher, D. Fang, and Y.C. Liu et al. Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch Science 306 2004 271 275
41. F. Gonzalvez, D. Lawrence, B. Yang, S. Yee, R. Pitti, and S. Marsters et al. TRAF2 sets a threshold for extrinsic apoptosis by tagging caspase-8 with a ubiquitin shutoff timer Molecular Cell 48 2012 888 899
42. H. Grassmé, J. Bock, J. Kun, and E. Gulbins Clustering of CD40 ligand is required to form a functional contact with CD40 The Journal of Biological Chemistry 277 2002 30289 30299
43. H. Grassmé, A. Jekle, A. Riehle, H. Schwarz, J. Berger, and K. Sandhoff et al. CD95 signaling via ceramide-rich membrane rafts The Journal of Biological Chemistry 276 2001 20589 20596
44. H. Grassmé, H. Schwarz, and E. Gulbins Molecular mechanisms of ceramide-mediated CD95 clustering Biochemical and Biophysical Research Communications 284 2001 1016 1030
45. M. Grell, E. Douni, H. Wajant, M. Löhden, M. Clauss, and B. Maxeiner et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor Cell 83 1995 793 802
46. C. Gunther, E. Martini, N. Wittkopf, K. Amann, B. Weigmann, and H. Neumann et al. Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis Nature 477 2011 335 339
47. O. Halaas, R. Vik, A. Ashkenazi, and T. Espevik Lipopolysaccharide induces expression of APO2 ligand/TRAIL in human monocytes and macrophages Scandinavian Journal of Immunology 51 2000 244 250
48. P.B. Harbury, T. Zhang, P.S. Kim, and T. Alber A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants Science 262 1993 1401 1407
49. S. He, L. Wang, L. Miao, T. Wang, F. Du, and L. Zhao et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha Cell 137 2009 1100 1111
50. A.M. Hohlbaum, S. Moe, and A. Marshak-Rothstein Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival The Journal of Experimental Medicine 191 2000 1209 1220
51. N. Holler, R. Zaru, O. Micheau, M. Thome, A. Attinger, and S. Valitutti et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule Nature Immunology 1 2000 489 495
52. H. Huet, A. Schuller, J. Li, J. Johnson, B. Dombrecht, and K. Meerschaert et al. TAS266, a novel tetrameric nanobody agonist targeting death receptor 5 (DR5), elicits superior antitumor efficacy than conventional DR5-targeted approaches Cancer Research 72 2012 Supplement 1: Abstract 3853
53. M.A. Hughes, N. Harper, M. Butterworth, K. Cain, G.M. Cohen, and M. MacFarlane Reconstitution of the death-inducing signaling complex reveals a substrate switch that determines CD95-mediated death or survival Molecular Cell 35 2009 265 279
54. A. Ikner, and A. Ashkenazi TWEAK induces apoptosis through a death-signaling complex comprising receptor-interacting protein 1 (RIP1), Fas-associated death domain (FADD), and caspase-8 The Journal of Biological Chemistry 286 2011 21546 21554
55. M. Irmler, M. Thome, M. Hahne, P. Schneider, B. Hofmann, and V. Steiner et al. Inhibition of death receptor signals by cellular FLIP Nature 388 1997 190 195
56. S.H. Jia, J. Parodo, A. Kapus, O.D. Rotstein, and J.C. Marshall Dynamic regulation of neutrophil survival through tyrosine phosphorylation or dephosphorylation of caspase-8 The Journal of Biological Chemistry 283 2008 5402 5413
57. Z. Jin, Y. Li, R. Pitti, D. Lawrence, V.C. Pham, and J.R. Lill et al. Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling Cell 137 2009 721 735
58. M. Jo, T.H. Kim, D.W. Seol, J.E. Esplen, K. Dorko, and T.R. Billiar et al. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand Nature Medicine 6 2000 564 567
59. R.W. Johnstone, A.J. Frew, and M.J. Smyth The TRAIL apoptotic pathway in cancer onset, progression and therapy Nature Reviews. Cancer 8 2008 782 798
60. S. Jouan-Lanhouet, M.I. Arshad, C. Piquet-Pellorce, C. Martin-Chouly, G. Le Moigne-Muller, and F. Van Herreweghe et al. TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation Cell Death and Differentiation 19 2012 2003 2014
61. W.J. Kaiser, J.W. Upton, A.B. Long, D. Livingston-Rosanoff, L.P. Daley-Bauer, and R. Hakem et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice Nature 471 2011 368 372
62. A. Kawahara, Y. Ohsawa, H. Matsumura, Y. Uchiyama, and S. Nagata Caspase-independent cell killing by Fas-associated protein with death domain The Journal of Cell Biology 143 1998 1353 1360
63. N. Keller, J. Mares, O. Zerbe, and M.G. Gruetter Structural and biochemical studies on procaspase-8: New insights on initiator caspase activation Structure 17 2009 438 448
64. T.J. Kemp, J.S. Kim, S.A. Crist, and T.S. Griffith Induction of necrotic tumor cell death by TRAIL/Apo-2L Apoptosis 8 2003 587 599
65. F.C. Kischkel, S. Hellbardt, I. Behrmann, M. Germer, M. Pawlita, and P.H. Krammer et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor The EMBO Journal 14 1995 5579 5588
66. F.C. Kischkel, D.a. Lawrence, A. Chuntharapai, P. Schow, K.J. Kim, and A. Ashkenazi Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5 Immunity 12 2000 611 620
67. F.C. Kischkel, D.A. Lawrence, A. Tinel, H. LeBlanc, A. Virmani, and P. Schow et al. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8 The Journal of Biological Chemistry 276 2001 46639 46646
68. S.L. Kohlhaas, A. Craxton, X.-M. Sun, M.J. Pinkoski, and G.M. Cohen Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis The Journal of Biological Chemistry 282 2007 12831 12841
69. A. Krippner-Heidenreich, F. Tübing, S. Bryde, S. Willi, G. Zimmermann, and P. Scheurich Control of receptor-induced signaling complex formation by the kinetics of ligand/receptor interaction The Journal of Biological Chemistry 277 2002 44155 44163
70. A. Krueger, S. Baumann, P.H. Krammer, and S. Kirchhoff FLICE-inhibitory proteins: Regulators of death receptor-mediated apoptosis Molecular and Cellular Biology 21 2001 8247 8254
71. D. Lawrence, Z. Shahrokh, S. Marsters, K. Achilles, D. Shih, and B. Mounho et al. Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions Nature Medicine 7 2001 383 385
72. M.S. Lawrence, P. Stojanov, C.H. Mermel, J.T. Robinson, L.A. Garraway, and T.R. Golub et al. Discovery and saturation analysis of cancer genes across 21 tumour types Nature 505 2014 495 501
73. K.-H. Lee, C. Feig, V. Tchikov, R. Schickel, C. Hallas, and S. Schütze et al. The role of receptor internalization in CD95 signaling The EMBO Journal 25 2006 1009 1023
74. E.-W. Lee, J.-H. Kim, Y.-H. Ahn, J. Seo, A. Ko, and M. Jeong et al. Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis Nature Communications 3 2012 1 12
75. C. Menke, L. Bin, J. Thorburn, K. Behbakht, H.L. Ford, and A. Thorburn Distinct TRAIL resistance mechanisms can be overcome by proteasome inhibition but not generally by synergizing agents Cancer Research 71 2011 1883 1892
76. O. Meurette, A. Rebillard, L. Huc, G. Le Moigne, D. Merino, and O. Micheau et al. TRAIL induces receptor-interacting protein 1-dependent and caspase-dependent necrosis-like cell death under acidic extracellular conditions Cancer Research 67 2007 218 226
77. O. Micheau, and J. Tschopp Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes Cell 114 2003 181 190
78. D.M. Moquin, T. McQuade, and F.K. Chan CYLD deubiquitinates RIP1 in the TNFalpha-induced necrosome to facilitate kinase activation and programmed necrosis PLoS One 8 2013 e76841
79. J.M. Murphy, P.E. Czabotar, J.M. Hildebrand, I.S. Lucet, J.G. Zhang, and S. Alvarez-Diaz et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism Immunity 39 2013 443 453
80. M. Muzio, A.M. Chinnaiyan, F.C. Kischkel, K. O'Rourke, A. Shevchenko, and J. Ni et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex Cell 85 1996 817 827
81. S. Nagata Apoptosis by death factor Cell 88 1997 355 365
82. M. Naito, U. Hainz, U.E. Burkhardt, B. Fu, D. Ahove, and K.E. Stevenson et al. CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells Cancer Immunology, Immunotherapy 62 2013 347 357
83. I. Naumann, R. Kappler, D. von Schweinitz, K.-M. Debatin, and S. Fulda Bortezomib primes neuroblastoma cells for TRAIL-induced apoptosis by linking the death receptor to the mitochondrial pathway Clinical Cancer Research 17 2011 3204 3218
84. L.A. O' Reilly, L. Tai, L. Lee, E.A. Kruse, S. Grabow, and W.D. Fairlie et al. Membrane-bound Fas ligand only is essential for Fas-induced apoptosis Nature 461 2009 659 663
85. M.A. O'Donnell, E. Perez-Jimenez, A. Oberst, A. Ng, R. Massoumi, and R. Xavier et al. Caspase 8 inhibits programmed necrosis by processing CYLD Nature Cell Biology 13 2011 1437 1442
86. A. Oberst, C.P. Dillon, R. Weinlich, L.L. McCormick, P. Fitzgerald, and C. Pop et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis Nature 471 2011 363 367
87. A. Oberst, C. Pop, A.G. Tremblay, V. Blais, J.-B. Denault, and G.S. Salvesen et al. Inducible dimerization and inducible cleavage reveal a requirement for both processes in caspase-8 activation The Journal of Biological Chemistry 285 2010 16632 16642
88. G. Papoff Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor The Journal of Biological Chemistry 274 1999 38241 38250
89. C. Perez, I. Albert, K. DeFay, N. Zachariades, L. Gooding, and M. Kriegler A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact Cell 63 1990 251 258
90. M.E. Peter, and P.H. Krammer The CD95(APO-1/Fas) DISC and beyond Cell Death and Differentiation 10 2003 26 35
91. C.M. Pickart Back to the future with ubiquitin Cell 116 2004 181 190
92. R.M. Pitti, S.A. Marsters, S. Ruppert, C.J. Donahue, A. Moore, and A. Ashkenazi Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family The Journal of Biological Chemistry 271 1996 12687 12690
93. C. Pop, A. Oberst, M. Drag, B.J. Van Raam, S.J. Riedl, and D.R. Green et al. FLIPL induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity The Biochemical Journal 433 2011 447 457
94. C.A. Ray, R.A. Black, S.R. Kronheim, T.A. Greenstreet, P.R. Sleath, and G.S. Salvesen et al. Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme Cell 69 1992 597 604
95. M.S. Rosendahl, S.C. Ko, D.L. Long, M.T. Brewer, B. Rosenzweig, and E. Hedl et al. Identification and characterization of a pro-tumor necrosis factor-alpha-processing enzyme from the ADAM family of zinc metalloproteases The Journal of Biological Chemistry 272 1997 24588 24593
96. A. Rossin, M. Derouet, F. Abdel-Sater, and A.-O. Hueber Palmitoylation of the TRAIL receptor DR4 confers an efficient TRAIL-induced cell death signalling The Biochemical Journal 419 2009 185 192
97. C. Scaffidi, I. Schmitz, P.H. Krammer, and M.E. Peter The role of c-FLIP in modulation of CD95-induced apoptosis The Journal of Biological Chemistry 274 1999 1541 1548
98. K. Schleich, U. Warnken, N. Fricker, S. Oeztuerk, P. Richter, and K. Kammerer et al. Stoichiometry of the CD95 death-inducing signaling complex: Experimental and modeling evidence for a death effector domain chain model Molecular Cell 47 2012 306 319
99. P. Schneider, N. Holler, J. Bodmer, M. Hahne, K. Frei, and A. Fontana et al. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity Nature 187 1998 1205 1213
100. P. Schneider, R. Schwenzer, E. Haas, F. Mühlenbeck, G. Schubert, and P. Scheurich et al. TWEAK can induce cell death via endogenous TNF and TNF receptor 1 European Journal of Immunology 29 1999 1785 1792
101. L.M. Sedger, D.M. Shows, R.a. Blanton, J.J. Peschon, R.G. Goodwin, and D. Cosman et al. IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression Journal of Immunology 163 1999 920 926
102. O. Seifert, A. Plappert, S. Fellermeier, M. Siegemund, K. Pfizenmaier, and R.E. Kontermann Tetravalent antibody-scTRAIL fusion proteins with improved properties Molecular Cancer Therapeutics 13 2014 101 111
103. J. Senft, B. Helfer, and S.M. Frisch Caspase-8 interacts with the p85 subunit of phosphatidylinositol 3-kinase to regulate cell adhesion and motility Cancer Research 67 2007 11505 11509
104. D.A. Sharp, D.A. Lawrence, and A. Ashkenazi Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis The Journal of Biological Chemistry 280 2005 19401 19409
105. H.B. Shu, D.R. Halpin, and D.V. Goeddel Casper is a FADD- and caspase-related inducer of apoptosis Immunity 6 1997 751 763
106. R.M. Siegel Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations Science 288 2000 2354 2357
107. M.R. Sprick, M.a. Weigand, E. Rieser, C.T. Rauch, P. Juo, and J. Blenis et al. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2 Immunity 12 2000 599 609
108. L. Sun, H. Wang, Z. Wang, S. He, S. Chen, and D. Liao et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase Cell 148 2012 213 227
109. T. Teitz, T. Wei, M.B. Valentine, E.F. Vanin, J. Grenet, and V.A. Valentine et al. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN Nature Medicine 6 2000 529 535
110. M. Thome, and J. Tschopp Regulation of lymphocyte proliferation and death by flip Nature Reviews. Immunology 1 2001 50 58
111. B.J. Van Raam, and G.S. Salvesen Proliferative versus apoptotic functions of caspase-8 hetero or homo: The caspase-8 dimer controls cell fate Biochimica et Biophysica Acta 1824 2012 113 122
112. P. Vandenabeele, L. Galluzzi, T. Vanden Berghe, and G. Kroemer Molecular mechanisms of necroptosis: An ordered cellular explosion Nature Reviews. Molecular Cell Biology 11 2010 700 714
113. N. Vanlangenakker, M.J. Bertrand, P. Bogaert, P. Vandenabeele, and T. Vanden Berghe TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members Cell Death & Disease 2 2011 e230
114. N. Vanlangenakker, T. Vanden Berghe, and P. Vandenabeele Many stimuli pull the necrotic trigger, an overview Cell Death and Differentiation 19 2012 75 86
115. E. Varfolomeev, H. Maecker, D. Sharp, D. Lawrence, M. Renz, and D. Vucic et al. Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand The Journal of Biological Chemistry 280 2005 40599 40608
116. E.E. Varfolomeev, M. Schuchmann, V. Luria, N. Chiannilkulchai, J.S. Beckmann, and I.L. Mett et al. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally Immunity 9 1998 267 276
117. P.O. Vidalain, O. Azocar, C. Servet-Delprat, C. Rabourdin-Combe, D. Gerlier, and S. Manié CD40 signaling in human dendritic cells is initiated within membrane rafts The EMBO Journal 19 2000 3304 3313
118. D. Vucic, V.M. Dixit, and I.E. Wertz Ubiquitylation in apoptosis: A post-translational modification at the edge of life and death Nature Reviews. Molecular Cell Biology 12 2011 439 452
119. K.W. Wagner, E.A. Punnoose, T. Januario, D.A. Lawrence, R.M. Pitti, and K. Lancaster et al. Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL Nature Medicine 13 2007 1070 1077
120. H. Walczak, M.A. Degli-Esposti, R.S. Johnson, P.J. Smolak, J.Y. Waugh, and N. Boiani et al. TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL The EMBO Journal 16 1997 5386 5397
121. H. Walczak, R.E. Miller, K. Ariail, B. Gliniak, T.S. Griffith, and M. Kubin et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo Nature Medicine 5 1999 157 163
122. H. Wang, L. Sun, L. Su, J. Rizo, L. Liu, and F. Wang et al. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3 Molecular Cell 54 2014 133 146
123. L. Wang, F. Du, and X. Wang TNF-alpha induces two distinct caspase-8 activation pathways Cell 133 2008 693 703
124. S.R. Wiley, K. Schooley, P.J. Smolak, W.S. Din, C.P. Huang, and J.K. Nicholl et al. Identification and characterization of a new member of the TNF family that induces apoptosis Immunity 3 1995 673 682
125. N.S. Wilson, V. Dixit, and A. Ashkenazi Death receptor signal transducers: Nodes of coordination in immune signaling networks Nature Immunology 10 2009 348 355
126. N.S. Wilson, A. Yang, B. Yang, S. Couto, H. Stern, and A. Gogineni et al. Proapoptotic activation of death receptor 5 on tumor endothelial cells disrupts the vasculature and reduces tumor growth Cancer Cell 22 2012 80 90
127. N.S. Wilson, B. Yang, A. Yang, S. Loeser, S. Marsters, and D. Lawrence et al. An Fcγ receptor-dependent mechanism drives antibody-mediated target-receptor signaling in cancer cells Cancer Cell 19 2011 101 113
128. W.C. Yeh, A. Itie, A.J. Elia, M. Ng, H.B. Shu, and A. Wakeham et al. Requirement for casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development Immunity 12 2000 633 642
129. D.W. Zhang, J. Shao, J. Lin, N. Zhang, B.J. Lu, and S.C. Lin et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis Science 325 2009 332 336
130. Q. Zhou, S. Snipas, K. Orth, M. Muzio, V.M. Dixit, and G.S. Salvesen Target protease specificity of the viral serpin CrmA - Analysis of five caspases The Journal of Biological Chemistry 272 1997 7797 7800